Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Pfizer's stock has suffered a brutal 16.44% drop in April, despite flexing strong Q4 earnings with a 37.2% EPS beat. Over the ...

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

We recently published a list of the 10 Safe Dividend Stocks with Yields Above 5%. In this article, we are going to take a ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S.

Pfizer shares inched up 0.4% on Friday, riding a surge in trading volume that was 33% above average—call it a micro-win. Wall ...

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growthStrategy builds on technology and science leadership, focusing on high-growth, high-value ...

Stock futures rose on Sunday as Wall Street looks to gauge President Donald Trump's latest tariff moves. S&P 500 futures ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...